List of insiders holdings for Jade Biosciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
2025-05-01 18:31:59 | 7,249,356 0 |
7,249,356 | Form 13D |
2 | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES 10% Owner |
2024-02-20 19:09:57 | 3,807,315 0 |
3,807,315 | Form 13D |
3 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
2025-04-30 16:52:39 | 0 2,387,280 |
2,387,280 | Form 4 |
4 | King Andrew James See Remarks |
2025-05-01 17:27:21 | 1,349,453 0 |
1,349,453 | Form 3 |
5 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
2025-04-30 16:51:40 | 1,324,954 0 |
1,324,954 | Form 13D |
6 | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Former 10% Owner |
2024-02-14 15:08:31 | 1,211,696 0 |
1,211,696 | Form 13G |
7 | Kocinsky Hetal Chief Medical Officer |
2025-05-01 17:30:01 | 539,758 0 |
539,758 | Form 3 |
8 | Balta Elizabeth See Remarks |
2025-05-01 17:32:25 | 485,782 0 |
485,782 | Form 3 |
9 | Quick Jonathan See Remarks |
2025-05-01 17:22:47 | 404,818 0 |
404,818 | Form 3 |
10 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
2024-05-17 19:10:13 | 343,381 0 |
343,381 | Form 4 |
11 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2024-02-07 18:00:11 | 111,539 0 |
111,539 | Form 4 |
12 | Gillies Hunter CHIEF MEDICAL OFFICER |
2024-06-14 18:00:05 | 89,112 0 |
89,112 | Form 4 |
13 | Verwijs Marinus CHIEF TECHNICAL OFFICER |
2024-06-14 18:00:07 | 68,800 0 |
68,800 | Form 4 |
14 | Pigot Timothy CHIEF COMMERCIAL OFFICER |
2024-01-24 18:00:32 | 67,877 0 |
67,877 | Form 4 |
15 | Atlas Venture Fund XII L.P. 10% Owner |
2025-04-30 16:29:11 | 51,406 0 |
51,406 | Form 13D |
16 | Atlas Venture Fund XII L.P. Atlas Venture Associates XII L.P. Atlas Venture Associates XII LLC 10% Owner |
2025-04-30 16:29:11 | 51,406 0 |
51,406 | Form 13D |
17 | Eldridge George A SEE REMARKS |
2024-06-14 18:00:09 | 33,785 0 |
33,785 | Form 4 |
18 | Lavelle Erin Director |
2025-05-01 18:15:30 | 23,017 0 |
23,017 | Form 4 |
19 | Klein Lawrence Otto Director |
2025-05-01 18:10:20 | 23,017 0 |
23,017 | Form 4 |
20 | CAIN CHRISTOPHER W. Director |
2025-05-01 18:07:58 | 23,017 0 |
23,017 | Form 4 |
21 | DOBMEIER ERIC Director |
2025-05-01 18:00:21 | 23,017 0 |
23,017 | Form 4 |
22 | Dake Benjamin T SEE REMARKS |
2024-08-02 18:00:22 | 15,759 0 |
15,759 | Form 4 |
23 | Resnick Joshua Director |
2024-06-07 18:00:16 | 12,500 0 |
12,500 | Form 4 |
24 | Dorval Allison Director |
2024-06-07 18:00:05 | 12,500 0 |
12,500 | Form 4 |
25 | Dable Habib J Director |
2024-06-07 18:00:07 | 12,500 0 |
12,500 | Form 4 |
26 | GRAYZEL DAVID S. Director |
2024-06-07 18:00:10 | 12,500 0 |
12,500 | Form 4 |
27 | Iwicki Mark T Director |
2024-06-07 18:00:12 | 12,500 0 |
12,500 | Form 4 |
28 | Katabi Maha Director 10% Owner |
2024-06-07 18:00:14 | 12,500 0 |
12,500 | Form 4 |
29 | Santel Donald J Director |
2024-06-07 18:00:18 | 12,500 0 |
12,500 | Form 4 |
30 | Frohlich Tom Chief Executive Officer |
2025-05-19 16:54:17 | 6,000 0 |
6,000 | Form 4 |